Hormesis, allostasis, and Selye's general alarm reaction: Cardiomyopathy, calciphylaxis, and catatoxic (protective steroids) related to current interest in heat shock protein, antioxidants, and dehydroepiandrosterone

Developmental Brain Dysfunction

Volumn 10, Issue 6, 1997, Pages 359-370

  Regelson, William ^a   Kalimi, Mohammed ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

'Aggressologie'; Allostasis; Calciphylaxis; Cardiomyopathy; Catatoxic steroids; Dehydroepiandrosterone; Heat shock protein; Hormesis; Inflammation; Selye; Str ess conditioning; Stress

Indexed keywords

ANTIOXIDANT; CARVEDILOL; CATATOXIC STEROID; CATECHOLAMINE; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; HEAT SHOCK PROTEIN; HISTAMINE; INTERLEUKIN 6; PHOSPHOLIPASE A2 INHIBITOR; PRASTERONE; PREGNENOLONE; SEROTONIN;

AGING; BLOOD VESSEL INJURY; CALCINOSIS; CARDIOMYOPATHY; EDEMA; HEART VENTRICLE HYPERTROPHY; HUMAN; INFLAMMATION; INJURY; MAST CELL; REACTION ANALYSIS; REVIEW; STRESS;

EID: 0031544787     PISSN: 10195815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Selye H: Stress. Montreal, ACTA, 1950.
2. Selye H: The Stress of Life. New York, McGraw Hill, 1956.
3. Selye H: Stress in Health and Disease. Boston/London, Butterworths, 1976.
4. Selye H: Stress, cancer and the mind; in Tache J, Selye H, Day SB (eds): Cancer, Stress and Death. New York, Plenum Medical Book, 1977.
5. Selye H: Selye's Guide to Stress Research. New York, Van Nostrand/Rheinhold, 1980.
6. Regelson W, Loria R, Kalimi M: Hormonal intervention and buffer hormones or state dependency. The role of dehydroepiandrosterone (DHEA), thyroid hormone, estrogen and hypophysectomy in aging. Ann NY Acad Sci 1988;518:260-273.
7. Usdine E, Kvetnansky R, Axelrod J: Stress: The Role of Catecholamines and Other Neurotransmitters. New York, Gordon & Breach, 1983, chap 6, 7.
8. Canova C, Baubet C, Chevalier G, Brachet P, Wion D: Noradrenaline inhibits the programmed cell death induced by 1,25 hydroxyvitamin D3 in glioma. Eur J Pharmacol 1997;319: 365-368.
9. Cooper EL (ed): Stress, Immunity and Aging. New York, Dekker, 1984.
10. Koob GF, Thatcher-Briton K, Tazi A, Le Moal M: Behavioral pharmacology in stress: Focus on CNS corticotropin-releasing factor. Adv Exp Med Biol 1988;245:25-34.
11. Laborit H: Stress and Cellular Function. Philadelphia, Lippincott, 1959.
12. Smith-Sonneborn J: The role of the stress protein response in hormesis; in Calabrese EJ (ed): Biological Effects of Low Level Exposures to Chemicals and Radiation. Chelsea, Lewis, 1992, pp 41-52.
13. Wickelgren I: Heat shock protein linked to stroke protection. Science 1997;278:1405.
14. Conde AG, Lav SS, Dillmann WH, Mestril R: Induction of heat shock proteins by tyrosine kinase inhibitors in rat cardiomyocytes and myogenic cells confers protection against simulated ischemia. J Mol Cell Cardiol 1997;29:1927-1938.
15. Smith-Sonneborn J: Exercise induced stress response as an adaptive tolerance strategy. Environ Health, in press.
16. Yamashita N, Hoshida S, Nishida M, Igarashi J, Aoki K, Hori M, Kuzuya T, Tada M: Time course of tolerance to ischemia reperfusion injury and induction of heat shock protein 70 by heat stress in the rat heart. J Mol Cell Cardiol 1997;29: 1815-1821.
17. Pardue ML, Feramisco JR, Lindquist S (eds): Stress Induced Proteins. New York, Liss, 1988.
18. Schlesinger MJ, Santoro MG, Garaci E (eds): Stress Proteins, Induction and Function. Berlin, Springer, 1990.
19. Morimoto I, Tissieres A, Georgopoulos C (eds): Stress Proteins in Biology and Medicine. Cold Spring Harbor, Cold Spring Harbor Lab Press, 1990.
20. Nover L (ed): Heat Shock Response. Boca Raton, CRC Press, 1991.
21. Mayer RJ, Brown IR: Heat Shock Proteins in The Nervous System. New York, Academic Press, 1994.
22. Kregel KC, Mosely PL, Skidmore R, Gutierrge, JA, Guerriro V Jr: HSP 70 accumulation in tissues of heat-stressed rats is blunted with advancing age. J Appl Physiol 1995;79:1673-1678.
23. Locke M, Tanguay RM: Diminished heat shock response in the aged myocardium. Cell Stress Chaperones 1996;1:251-260.
24. Nitta Y, Abe-K, Aoki M, Ohno I, Isoyama S: Diminished heat shock protein 70 mRNA induction in aged rat hearts after ischemia. Am J Physiol 1994;267:795-803.
25. Pardue S, Groshan K, Raese JD, Morrison-Bogorad M: HSP 70 mRNA induction is reduced in neurons of aged rat hippocampus after thermal stress. Neurobiol Aging 1992;13:661-672.
26. Montagnier L, Olivier R, Pasquier C (eds): Oxidative Stress in Cancer and AIDS and Neurodegenerative Diseases. New York, Dekker, 1998.
27. Lave L, Loriaux DL, Chrousos GP: Glucocorticoid antagonists and the role of glucocorticoids at the resting and stressed state. Adv Exp Med Biol 1988;245:225-235.
28. Selye H: Hormones and Resistance, pt 2. New York, Springer, 1970.
29. Selye H: Prevention of myocardial necrosis with catatoxic steroids. J Mol Cell Cardiol 1970;1: 91-99.
30. Selye H: Resistance to various pesticides induced by catatoxic steroids. Arch Environ Health 1970: 21:706-710.
31. Selye H, Yeghiayan E, Mecs I: Prevention of nicotine intoxication by catatoxic steroids. Pharmacodynamics 1970;83:235-238.
32. Selye H: Prevention of colchicine intoxication by catatoxic steroids. Endocrin Exp 1970;4:71-76.
33. Tache Y, Tache J, Selye H: Inhibition of the effects of alfathesin and other steroid anaesthetics by catatoxic steroids in rats. Arzneimittelforschung 1975;25:1603-1606.
34. Selye H: Protection by catatoxic steroids against phenindione overdosage. Thromb Diath Haemorr 1970;3:77-81.
35. Selye H, Szabo S, Mecs I: Protection by catatoxic steroids against the paralysis caused by combined treatment with thyroxine and methylphenidate. Neuropharmacology 1972;11:693-697.
36. Selye H, Szabo S: Protection by various catatoxic steroids and estradiol against the fatal hemorrhagic syndrome produced by bishydroxy coumarin in the rat. Vox Sang 1972;22:229-235.
37. Selye H, Szabo S, Kourounakis PL: Protection by catatoxic steroids, phenobarbital and diphenylhydantoin against methaqualone intoxication. Steroids Lipid Res 1972;3:156-159.
38. Selye H, Szabo S: Protection against haloperidol by catatoxic steroids. Psychopharmacologia 1972; 24:430-434.
39. Selye H, Goldi, I, Strebel R: Effect of anabolic hormones and ferric dextran upon the progeria-like syndrome produced by dihydrotachysterol. Gerontologia 1963;7:94-104.
40. Selye H, Tuchweber B, Jacqmin M: Protection by various anabolic steroids against dihdrotachysterol induced calcinosis and catabolism. Acta Endocrinol 1965;49:589-601.
41. Lefebvre F, Aszbo S: Effects of catatoxic steroids on acute and chronic poisoning with aniline. J Physiol (Paris) 1971;63:511-516.
42. Selye H: Prevention of indomethacin-induced intestinal ulcers by various catatoxic steroids. Exp Med Surg 1970:25:169-178.
43. Selye H: Resistance to picrotoxin poisoning induced by catatoxic steroids. Agents Actions 1970; 1:133-135.
44. Selye H: Protection by catotoxic steroids against cyclophosphamide-induced organ lesions. Virchows Arch 1970:351:248-259.
45. Selye H: Protection by catatoxic steroids against cyclohexamide intoxication. Tox Appl Pharmacol 1970;17:721-725.
46. Selye H, Solymoss B: Protection by catatoxic steroids against meprobamate. Neuropharmacology 1970;9:327-332.
47. Selye H: Experimental Cardiovascular Diseases, pt 1, 2. New York, Springer, 1970.
48. Lax ER, Baumann P, Schriefers H: Changes in the activities of microsomal enzymes involved in hepatic steroid metabolism in the rat after administration of androgenic, estrogenic, progestational, anabolic and catabolic steroids. Chem Pharmacol 1984;33:1235-1241.
49. Wheatley D (ed): Stress and the Heart. New York, Raven Press, 1981.
50. Selye H: The Pluricasual Cardiomyopathics. Springfield, Thomas, 1961.
51. Selye H: Calciphylaxis. Chicago, Chicago University Press, 1962.
52. MacLean C, Brahn E: Systemic lupus erythematosis: Calciphylaxis induced cardiomyopathy. J Rheumatol 1995;22:177-179.
53. Fischer AH, Morris DJ: Pathogenesis of calciphylaxis: Study of three cases with literature review. Hum Pathol 1995;26:1055-1064.
54. Tajima M, Isoyama S, Nitta Y, Abe K: Attenuation of heat shock protein expression by coronary occlusion in hypertrophic hearts. Am J Physiol 1997;273:526-533.
55. Walentynowicz O, Wrzolkowa T: Pathogenesis of heart myofibril lesions in experimental vitamin D induced cardionecrosis. Exp Mol Pathol 1995; 63:200-209.
56. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T: Emergency room triage with acute chest pain by means of rapid testing for cardiac Troponin T or Troponin I. N Engl J Med 1997;337:1648-1653.
57. Goodman Y, Bruce AJ, Cheng B, Mattson MP: Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 1996;66:1836-1844.
58. Jesse RL, Loesser K, Eich DM, Yong Z-Q, Hess ML, Nestler JE: Dehydroepiandrosterone inhibits human platlet aggregation in vitro and in vivo. Ann NY Acad Sci 1985;774:281-290.
59. Abd-Elfattah ASA, Wechsler AS (eds): Purines and Myocardial Protection. Norwell, Kluwer, 1996.
60. Kleber FX, Sabin GV, Winter UJ, Reindl I, Beil S, Wenzel M, Fisher M, Doering W: Angiotensin-converting enzyme inhibitors in preventing remodeling and development of heart failure after acute myocardial infarction. Am J Cardiol 1997: 80:162-167.
61. Ruffalo RR Jr, Feuerstein GZ: Pharmacology of carvedilol: Rationale for use in hypertension, coronary aratery disease and congestive heart failure. Cardiovasc Drugs Ther 1997;11(suppl):247-256.
62. Wollert KC, Drexler H: The kallikrein-kinin system in post-myocardial infarction cardiac remodeling. Am J Cardiol 1997;80:158-161.
63. Kobori H, Ichihara A, Suzuki H, Takenaka T, Miyashita Y, Harashi M, Saruta T: Role of angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism. Am J Physiol 1997;273: H593-599 (2PT2).
64. Selye H: The Mast Cells. Washington, Butterworth, 1965.
65. Selye H: Anaphylactoid Edema. St. Louis, Green, 1968.
66. Munck A, Guyre PM: Glucocorticoid physiology, pharmacology and stress-. Adv Exp Med Biol 1986;196:81-96.
67. Lipsett MB, Tomita M, Brandon DD, Devroede MM, Lorinox DL, Chrousos G: Cortisol resistance in man. Adv Exp Med Biol 1956;196:97-109.
68. Kalimi M, Opoku J, Lu RS, Yanals S, Khalid M, Regelson W: Studies on the biochemical action and mechanism of DHEA; in Kalimi M, Regelson W (eds): The Biologic Role of DHEA. New York/ Berlin, de Gruyter, 1990, pp 397-404.
69. Kalimi M, Regelson W: The Biologic Role of Dehydroepiandrosterone (DHEA). New York/Berlin, de Gruyter, 1990.
70. Kalimi M, Bhafagoj Y, Loria R, Regelson W: Antiglucocorticoid effects of DHEA. A review. Mol Cell Biochem 1994;131:99-104.
71. Regelson W, Franson R: Phospholipase A2 (PLA2) as a 'death trigger' in the aging process. The use of PLA2 inhibitors as anti-aging substances. Ann NY Acad Sci 1990;621:262-276.
72. Loria LR, Inge T, Cook S, Szakal A, Regelson W: Protection against acute lethal viral infection with the native steroid dehydroepiandrosterone (DHEA). J Med Virol 1988;26:301-314.
73. Loria R, Regelson W, Padgett D: Immune response facilitation and resistance to virus and bacterial infections with dehydroepiandrosterone (DHEA); in Kalimi M, Regelson W (eds): The Biologic Role of DHEA. Berlin, de Gruyter, 1990, pp 131-155.
74. Araneo B, Dowell T, Woods ML, Judd M, Evans T: DHEAs as an effective vaccine adjuvant in elderly humans. Ann NY Acad Sci 1995;774:232-248.
75. Regelson W, Loria R, Kalimi M: Dehydroepiandrosterone (DHEA) the 'mother steroid', pt 1. Immunologic action. Ann NY Acad Sci 1994;719: 553-563.
76. Regelson W, Kalimi M: Dehydroepiandrosterone (DHEA) a pleiotroopic steroid. How can one steroid do so much? J Acad Prevent Aging 1996;1: 287-317.
77. Regelson W, Coleman C: Super-Hormone Promise. New York, Simon & Schuster, 1996.
78. Padgett DA, Sheridan JF, Loria RM: Steroid hormone regulation of a polyclonal Th2 immune response. Ann NY Acad Sci 1995:774:323-325.
79. Galle J, Mohr W, Lossnitzer K. Haferkamp O: Development of necrosis and its sequelae in the myocardium of polymyopathic hamsters (B108262). Virchows Arch B Cell Pathol Incl Mol Pathol 1981; 36:87-100.
80. Chury VZ, Neurtal M: Die Herz-und EKG-Veränderungen bei dem Progerie Syndrom der Ratte. A Gesamte Inn Med 1970;25:923-928.
81. Tuchweber B, Gabbiani G, Selye H: Effect of vitamin E and methyltestosterone upon the progeria-like syndrome produced by dihydrotachysterol. Am J Clin Nutr 1963;13:238-242.
82. Selye H, Goldie I, Streberl R: Effect of anabolic hormones and ferric dextran upon the progeria-like syndrome produced by dihydrotachysterol. Gerontologia (Basel) 1963;7:94-104.
83. Paz MA, Rhee J, Gallop PM: The presence and role of PQQ in red cells. The protective effect of PQQ against lead poisoning. IUDMB Symp 235: PQQ Quinoproteins, Capri, May 1994, pp 22-27.
84. Spencer NFL, Poynter ME, Hennebold J, Mu HH, Daynes RA: Does DHEAS restore immune competence in aged animals through its capacity to function as a natural modulator of peroxisome activities. Ann NY Acad Sci 1995;774:200-216.
85. Bellino FL, Darnes RA, Hornesby PJ, Laurin DH, Nestler JE: Dehydroepiandrosterone (DHEA) and aging. Ann NY Acad Sci 1995;774:1-350.
86. Lane MA, Ingram KK, Roth GS: Effects of aging and long term caloric restriction on DHEA sulfate in Rhesus monkeys. Ann NY Acad Sci 1995;774: 319-322.
87. Bernton E, Hoover D, Galloway R, Popp K: Adaptation to chronic stress in military trainees. Ann NY Acad Sci 1995;774:217-231.
88. Oda T, Akaike T, Hamamoto T, Suzuki F, Hirano T, Maeda H: Oxygen radicals in influenza induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 1989;244:974-976.
89. Lardy H, Kneer N, Bellei M, Bobyleva V: Induction of thermogenic enzymes by DHEA and its metabolites. Ann NY Acad Sci 1995;774:171-179.
90. McEwen BS: Protective and damaging effects of stress mediators. N Engl J Med 1998;338:171-179.